{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:12:08Z","timestamp":1790107928219,"version":"4.0.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.atherosclerosis.2026.120823","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T20:20:13Z","timestamp":1782850813000},"page":"120823","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Distribution of Lipoprotein(a) concentrations in children and young people with Familial Hypercholesterolemia (FH) compared to those without FH: A systematic review and narrative synthesis"],"prefix":"10.1016","volume":"419","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5813-0890","authenticated-orcid":false,"given":"Lorraine","family":"Priestley-Barnham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve E.","family":"Humphries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo","family":"Wray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2026.120823_bib1","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.atherosclerosis.2019.10.011","article-title":"HEART UK consensus statement on Lipoprotein(a): a call to action","volume":"291","author":"Cegla","year":"2019","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.120823_bib2","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jacc.2016.11.042","article-title":"A test in context: lipoprotein(a): diagnosis, prognosis, controversies, and emerging therapies","volume":"69","author":"Tsimikas","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"6144","key":"10.1016\/j.atherosclerosis.2026.120823_bib3","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/330132a0","article-title":"cDNA sequence of human apolipoprotein(a) is homologous to plasminogen","volume":"330","author":"McLean","year":"1987","journal-title":"Nature"},{"issue":"26","key":"10.1016\/j.atherosclerosis.2026.120823_bib4","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1056\/NEJMoa0902604","article-title":"Genetic variants associated with Lp(a) lipoprotein level and coronary disease","volume":"361","author":"Clarke","year":"2009","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120823_bib5","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11883-024-01187-6","article-title":"Lipoprotein(a): the resurgence of a long-neglected cardiovascular risk factor","volume":"26","author":"Kronenberg","year":"2024","journal-title":"Curr Atheroscler Rep"},{"issue":"10459","key":"10.1016\/j.atherosclerosis.2026.120823_bib6","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0140-6736(24)01308-4","article-title":"Lipoprotein(a) and cardiovascular disease","volume":"404","author":"Nordestgaard","year":"2024","journal-title":"Lancet"},{"issue":"21","key":"10.1016\/j.atherosclerosis.2026.120823_bib7","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1016\/j.jacc.2022.09.021","article-title":"Equivalent impact of elevated lipoprotein(a) and familial hypercholesterolemia in patients with atherosclerotic cardiovascular disease","volume":"80","author":"Hedegaard","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2026.120823_bib8","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2459\/JCM.0000000000001718","article-title":"Lipoprotein(a) in youth and childhood as a marker of cardiovascular risk stratification: a meta-analysis","volume":"26","author":"Borzillo","year":"2025","journal-title":"J Cardiovasc Med"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120823_bib9","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jacl.2023.03.010","article-title":"Lipoprotein(a) levels in children with homozygous familial hypercholesterolaemia: a cross-sectional study","volume":"17","author":"de Boer","year":"2023","journal-title":"J Clin Lipidol"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.120823_bib10","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.jacl.2018.07.014","article-title":"In pediatric familial hypercholesterolemia, lipoprotein(a) is more predictive than LDL-C for early onset of cardiovascular disease in family members","volume":"12","author":"Zawacki","year":"2018","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.atherosclerosis.2026.120823_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2019.09.005","article-title":"Current management of children and young people with heterozygous familial hypercholesterolaemia\u2014Heart UK statement of care","volume":"290","author":"Ramaswami","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2026.120823_bib12","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.atherosclerosis.2022.04.021","article-title":"Lipoprotein(a) and family history for cardiovascular disease in paediatric patients: a new frontier in cardiovascular risk stratification","volume":"349","author":"Pederiva","year":"2022","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2026.120823_bib13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.athplu.2024.06.002","article-title":"Lipoprotein(a) in children and adolescents with genetically confirmed familial hypercholesterolemia followed up at a specialized lipid clinic","volume":"57","author":"Johansen","year":"2024","journal-title":"Atherosclerosis Plus"},{"key":"10.1016\/j.atherosclerosis.2026.120823_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2024.132667","article-title":"Clinical reality and challenges with familial hypercholesterolemia patients' management: 2024 results from the regional Center for Rare Diseases (RCRD) Registry in Poland","volume":"419","author":"Lewek","year":"2025","journal-title":"Int J Cardiol"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.120823_bib15","first-page":"170","article-title":"Lipid and lipoprotein parameters for detection of familial hypercholesterolemia in childhood: the DECOPIN project","volume":"30","author":"Plana","year":"2018","journal-title":"Cl\u00edn Invest Arterioscler"},{"issue":"16","key":"10.1016\/j.atherosclerosis.2026.120823_bib16","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1093\/eurheartj\/ehac660","article-title":"Lipoprotein(a) levels in children with suspected familial hypercholesterolaemia: a cross-sectional study","volume":"44","author":"de Boer","year":"2023","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120823_bib17","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1023\/A:1007692419117","article-title":"Lipoprotein profiles, not anthropometric measures, correlate with serum lipoprotein(a) values in children: the Taipei Children Heart study","volume":"16","author":"Chu","year":"2000","journal-title":"Eur J Epidemiol"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120823_bib18","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s12291-012-0196-9","article-title":"Lipoprotein(a) in children of Asian Indian descendants and their Caucasian neighbors: the Slovak lipid community study","volume":"27","author":"Alberty","year":"2012","journal-title":"Indian J Clin Biochem"},{"key":"10.1016\/j.atherosclerosis.2026.120823_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-77689-5","article-title":"Prevalence and status of Lipoprotein(a) among Lebanese school children","volume":"10","author":"Gannag\u00e9-Yared","year":"2020","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120823_bib20","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41390-024-03108-4","article-title":"Lipoprotein(a) serum concentrations in children in relation to body mass index, age and sex","volume":"96","author":"St\u00fcrzebecher","year":"2024","journal-title":"Pediatr Res"},{"issue":"14","key":"10.1016\/j.atherosclerosis.2026.120823_bib21","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa2019910","article-title":"Evolocumab in pediatric heterozygous familial hypercholesterolemia","volume":"383","author":"Santos","year":"2020","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120823_bib22","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1001\/jamapediatrics.2023.6477","article-title":"Alirocumab in pediatric patients with heterozygous familial hypercholesterolemia: a randomized clinical trial","volume":"178","author":"Santos","year":"2024","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.atherosclerosis.2026.120823_bib23","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0009-3084(94)90142-2","article-title":"Structure and metabolism of lipoprotein(a)","volume":"67\u201368","author":"Knight","year":"1994","journal-title":"Chem Phys Lipids"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120823_bib24","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1172\/JCI117794","article-title":"Metabolism of lipoprotein(a) in humans","volume":"95","author":"Rader","year":"1995","journal-title":"J Clin Investig"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120823_bib25","doi-asserted-by":"crossref","DOI":"10.31083\/RCM26162","article-title":"Statins\u2014their effect on Lipoprotein(a) levels","volume":"26","author":"Granat","year":"2025","journal-title":"Rev Cardiovasc Med"},{"key":"10.1016\/j.atherosclerosis.2026.120823_bib26","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1161\/01.CIR.80.5.1313","article-title":"HMG CoA reductase inhibitors lower LDL cholesterol without reducing Lp(a) levels","volume":"80","author":"Kostner","year":"1989","journal-title":"Circulation"},{"issue":"21","key":"10.1016\/j.atherosclerosis.2026.120823_bib27","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1056\/NEJM199005243222104","article-title":"Relation of serum lipoprotein(a) concentration and lipoprotein phenotypes with presence of coronary heart disease in patients with familial hypercholesterolemia","volume":"322","author":"Seed","year":"1990","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120823_bib28","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2026.120823_bib29","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.atherosclerosis.2022.03.004","article-title":"Lipoprotein(a) levels from childhood to adulthood: data in nearly 3,000 children who visited a pediatric lipid clinic","volume":"349","author":"de Boer","year":"2022","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120823_bib30","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.jacl.2017.02.010","article-title":"Lipoprotein(a) and cardiovascular risk in familial hypercholesterolemia","volume":"11","author":"Sjouke","year":"2017","journal-title":"J Clin Lipidol"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2026.120823_bib31","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/ahg.12594","article-title":"Genetic determinants of the familial hypercholesterolaemia phenotype","volume":"89","author":"Humphries","year":"2025","journal-title":"Ann Hum Genet"},{"key":"10.1016\/j.atherosclerosis.2026.120823_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ahj.2025.03.019","article-title":"Design and rationale of Lp(a) HORIZON trial: assessing the effect of Lipoprotein(a) lowering with pelacarsen on major cardiovascular events in patients with CVD and elevated Lp(a)","volume":"287","author":"Cho","year":"2025","journal-title":"Am Heart J"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2026.120823_bib33","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/eurheartj\/ehae781","article-title":"Olpasiran lowering of lipoprotein(a) according to baseline levels: insights from the OCEAN(a)-DOSE study","volume":"46","author":"Kaur","year":"2025","journal-title":"Eur Heart J"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915026001899?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915026001899?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T19:57:55Z","timestamp":1790107075000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915026001899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":33,"alternative-id":["S0021915026001899"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2026.120823","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Distribution of Lipoprotein(a) concentrations in children and young people with Familial Hypercholesterolemia (FH) compared to those without FH: A systematic review and narrative synthesis","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2026.120823","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2026 Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"120823"}}